Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Non-Current Assets: 2023-2025

Historic Other Non-Current Assets for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $568,000.

  • Compass Therapeutics' Other Non-Current Assets changed negligibly% to $568,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $568,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $568,000 for FY2024, which is 77.50% up from last year.
  • According to the latest figures from Q3 2025, Compass Therapeutics' Other Non-Current Assets is $568,000, which was down 0.00% from $568,000 recorded in Q2 2025.
  • Compass Therapeutics' Other Non-Current Assets' 5-year high stood at $568,000 during Q3 2024, with a 5-year trough of $320,000 in Q1 2023.
  • For the 3-year period, Compass Therapeutics' Other Non-Current Assets averaged around $432,727, with its median value being $320,000 (2024).
  • Data for Compass Therapeutics' Other Non-Current Assets shows a peak YoY skyrocketed of 77.50% (in 2024) over the last 5 years.
  • Compass Therapeutics' Other Non-Current Assets (Quarterly) stood at $320,000 in 2023, then soared by 77.50% to $568,000 in 2024, then remained steady at $568,000 in 2025.
  • Its Other Non-Current Assets was $568,000 in Q3 2025, compared to $568,000 in Q2 2025 and $568,000 in Q1 2025.